HDAC9 and central nervous system cancer: ZN326 has also been reported to positively regulate the WNT pathway and HDAC transcription activities in glioma (Yu et al., 2019), both implicated in timing of oligodendrocyte development in the central nervous system (Marin-Husstege et al., 2002; Conway et al., 2012).